Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( (HK:2185) ).
Shanghai Bio-heart Biological Technology Co., Ltd. announced that its controlling shareholder, Philip Li Wang, plans to increase his shareholding in the company by purchasing additional H shares through Winning Powerful Limited, a company wholly owned by him. This move, estimated to involve up to HK$15 million, reflects Mr. Wang’s confidence in the company’s growth potential and long-term business prospects, while ensuring the company maintains a sufficient public float of shares.
More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
Shanghai Bio-heart Biological Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the biotechnology industry. The company focuses on developing biological technologies and products, with a market presence that includes the issuance of H shares on the Stock Exchange of Hong Kong.
Average Trading Volume: 2,437,681
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.09B
Learn more about 2185 stock on TipRanks’ Stock Analysis page.